Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0.030) Estimate, Sales $3.300M Miss $3.813M Estimate
Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0.030) Estimate, Sales $3.300M Miss $3.813M Estimate
Nephros 2023 年第四季度公认会计准则每股收益 (0.060 美元) 未达预期 (0.030)，销售额 330 万美元未达预期 381.3 万美元
Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.060) per share which missed the analyst consensus estimate of $(0.030) by 100 percent. The company reported quarterly sales of $3.300 million which missed the analyst consensus estimate of $3.813 million by 13.47 percent. This is a 29.01 percent increase over sales of $2.558 million the same period last year.
Nephros（纳斯达克股票代码：NEPH）公布的季度亏损为每股0.060美元，比分析师普遍预期的美元（0.030美元）低100％。该公司公布的季度销售额为33亿美元，比分析师共识估计的381.3万美元低13.47％。这比去年同期的255.8万美元销售额增长了29.01％。